Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
3 Stocks to Buy Following Guidance Upgrades
04:21pm, Thursday, 09'th May 2024
Guidance lifts are among the most positive announcements shareholders can hear, injecting confidence in the long-term picture. And that's precisely what these three companies have recently announced.
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
03:15pm, Tuesday, 07'th May 2024
Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart monitoring tech was approved for use in clinical studies.
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
02:04pm, Tuesday, 07'th May 2024
Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because much hinges on underlying breakthroughs.
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
11:33am, Tuesday, 07'th May 2024
Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.
US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
10:12am, Tuesday, 07'th May 2024
Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss whether the agency should approve its Alzheimer's disease drug, donanemab, on June 10.
Why Eli Lilly Stock Jumped by 4% Today
07:06pm, Monday, 06'th May 2024
The pharmaceutical powerhouse continues to remunerate its shareholders. It declared a fresh quarterly dividend.
Lilly (LLY) Reliance on International Sales: What Investors Need to Know
10:21am, Monday, 06'th May 2024
Examine the evolution of Lilly's (LLY) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Monday, 06'th May 2024
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
06:15am, Monday, 06'th May 2024
Eli Lilly and Co. NYSE: LLY reported strong Q1 2024 earnings, causing shares to soar towards all-time highs initially, but a sell-the-news reaction triggered in the following days. The medical sector
2 Top Stocks That Could Make You Richer in 2024
04:10am, Monday, 06'th May 2024
Alphabet just announced its first-ever dividend and a whopping $70 billion stock buyback. Eli Lilly's blockbuster weight-loss treatment is changing its customers' lives -- and delivering fortune-build
3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
02:49pm, Sunday, 05'th May 2024
Eli Lilly not only has an impressive track record for paying dividends but has also doubled its payouts in just five years. Coca-Cola has a dividend growth streak that spans 62 years.
3 No-Brainer Stocks to Buy in May
06:55am, Sunday, 05'th May 2024
It's always a good time to buy shares of Eli Lilly. Pfizer is undervalued and underrated.
Don't Wait for Fed to Cut Rates. Profit Now!
12:00pm, Saturday, 04'th May 2024
Investors wait for the Fed starting gun
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
08:30am, Saturday, 04'th May 2024
Eli Lilly's Mounjaro is a diabetes medication that competes with Novo Nordisk's Ozempic. Lilly is making strides in the weight-loss market, and its newest treatment may be a smashing success.
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
06:45am, Saturday, 04'th May 2024
The outlook for Pfizer's experimental obesity drug danuglipron is murky at best. Pfizer could pick up another obesity drug via an acquisition, but management says a near-term deal is unlikely.
